Fascaplysin Derivatives Are Potent Multitarget Agents against Alzheimer’s Disease: <i>in Vitro</i> and <i>in Vivo</i> Evidence

Hanbo Pan(Shanghai Jiao Tong University), Wei Cui(Van Andel Institute), Mengxiang Yang(Ningbo University), Xiaojun Yan(Zhejiang Ocean University), Fufeng Liu(Tianjin University of Science and Technology), Ke Zhang(Nanjing University of Chinese Medicine), Hongze Liang(Ningbo University), Hongda Qiu(Ningbo University), Haixiao Jin(Ningbo University), Difan Zhang(Pennsylvania State University), Haixing Wang(ZheJiang Institute For Food and Drug Control), Miaoman Lin(Ningbo University), Panpan Zhang(First Affiliated Hospital of Henan University of Science and Technology), Xiao Xiao(First Affiliated Hospital of Zhengzhou University), Yongmei Li(Ningbo University), Chenye Mou(Ningbo University), Weida Liang(Ningbo University), Ming He(Ningbo University)
ACS Chemical Neuroscience
October 22, 2019
Cited by 50


Related Papers